Genesystem Co., Ltd. (KOSDAQ:363250)

South Korea flag South Korea · Delayed Price · Currency is KRW
9,900.00
-20.00 (-0.20%)
Feb 21, 2025, 9:00 AM KST
42.65%
Market Cap 69.13B
Revenue (ttm) 1.57B
Net Income (ttm) -11.27B
Shares Out 7.03M
EPS (ttm) -1,623.49
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 12,272
Average Volume 36,198
Open 9,990.00
Previous Close 9,920.00
Day's Range 9,830.00 - 9,990.00
52-Week Range 5,390.00 - 12,800.00
Beta 0.61
RSI 47.41
Earnings Date n/a

About Genesystem

Genesystem Co., Ltd., a biotech engineering company, specializes in molecular testing solutions to target on-site testing needs. The company offers PCR systems, multiplex biochips, and PCR reagents. It also provides human pathogen assays, including novel coronavirus (SARS-CoV-2) detection kits, SARS-CoV-2/Flu/RSV simultaneous detection kits, and mycobacterium tuberculosis detection kits; veterinary diagnostics; food safety assays comprising foodborne pathogen detection kits, HALAL food testing kits, and meat species identification kits; and nuc... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2010
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 363250
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.